Linda Luijten
PhD student
My background
I obtained my bachelor’s and master’s degrees in medicine at the Erasmus University Rotterdam.
After completing my studies in 2015, I started working as a resident neurology not in training (ANIOS) at the Elisabeth-Tweesteden hospital Tilburg. In this hospital I started my residency training in neurology (AIOS) in 2016, which I expect to finalize in 2026. I completed traineeships in general neurology, acute neurology, neuro-intensive care, paediatric neurology, neurosurgery, academic neurology and clinical neurophysiology.
My main interest is in neuro-inflammatory diseases of both the central and peripheral nervous system. In 2020, I started as PhD-candidate at the department of neurology of the Erasmus University Centre Rotterdam.
My projects
My PhD trajectory focuses on clinical studies on the diagnosis, prognosis and treatment of Guillain-Barré syndrome (GBS).
Main aims of my research are to improve the recognition of GBS in clinical practice, to improve the current prognostic tools for prediction of the disease course of GBS and to develop an alternative design for the conduct of treatment studies on novel treatments for GBS. Using the results of these projects, we hope to facilitate the diagnostic process and improve the clinical care and treatment for patients with GBS.
A list of research articles
-
Evaluation of new treatments for GBS using real-world data
-
Study on GBS
A substantial proportion of patients with GBS do not respond sufficiently to the current proven effective treatment with intravenous immunoglobulins (IVIg) or plasma exchange. The rarity of the disease challenges the conduct of clinical trials, with no new effective treatments found in the past 30 years. Improved designs for conducting treatment studies and novel treatment […]
-
-
Mimics of GBS in The Netherlands
-
Study on GBS
Accurate and rapid diagnosis of GBS is important for adequate monitoring and treatment of patients. Since there is no definitive test, the diagnosis is based on clinical symptoms and signs found during neurological examination. Early diagnosis is often difficult due to the large diversity in symptoms and course of the disease. Furthermore, other diseases can […]
-
-
Early recognition of GBS with fluctuations and acute-onset CIDP
-
Study on CIDP and GBS
In 10% of the patients with GBS, secondary fluctuations occur and in 5% the diagnosis is eventually changed to acute-onset CIDP (A-CIDP). Early recognition of patients at risk for fluctuations or A-CIDP is important, because alternative treatment options can be considered in these patients. In this study, we aim to describe the clinical features of […]
-
